FDA Inspection 1245571 — Siegfried (Nantong) Pharmaceuticals Co., Ltd.
The FDA completed an inspection of Siegfried (Nantong) Pharmaceuticals Co., Ltd. on July 5, 2024 in Nantong. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 5, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nantong (China)